Publications in collaboration with researchers from Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (74)

2025

  1. Erratum: Author Correction: Metabolic reprogramming by Acly inhibition using SB-204990 alters glucoregulation and modulates molecular mechanisms associated with aging (Communications biology (2023) 6 1 DOI: 10.1038/s42003-023-04625-4.)

    Communications biology

  2. Glioblastoma progression is hindered by melatonin-primed mesenchymal stromal cells through dynamic intracellular and extracellular reorganizations

    Theranostics , Vol. 15, Núm. 7, pp. 3076-3097

  3. Higher plasma levels of endocannabinoids and analogues are correlated with a worse cardiometabolic profile in middle-aged adults

    Journal of Physiology and Biochemistry, Vol. 81, Núm. 1, pp. 173-184

2024

  1. Exploring Plasma Coenzyme Q10 Status in Paediatric Dyslipidaemia

    Antioxidants, Vol. 13, Núm. 8

  2. Hydroxycitrate delays early mortality in mice and promotes muscle regeneration while inducing a rich hepatic energetic status

    Aging Cell, Vol. 23, Núm. 9

  3. Protective effects of mesenchymal stromal cell-derived secretome on dermonecrosis induced in rabbits by Loxosceles intermedia spider venom

    Journal of Venomous Animals and Toxins Including Tropical Diseases, Vol. 30

2023

  1. Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

  2. Generation of mesenchymal stromal cells from urine-derived iPSCs of pediatric brain tumor patients

    Frontiers in Immunology, Vol. 14

  3. Metabolic reprogramming by Acly inhibition using SB-204990 alters glucoregulation and modulates molecular mechanisms associated with aging

    Communications Biology, Vol. 6, Núm. 1

  4. Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention

    BMJ

  5. Rationale for combined therapies in severe-to-critical COVID-19 patients

    Frontiers in Immunology, Vol. 14

  6. Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses

    Frontiers in Cell and Developmental Biology, Vol. 11

2022

  1. Considerations for Clinical Use of Mesenchymal Stromal Cells

    Handbook of Stem Cell Therapy: Volume 1 (Springer Nature), pp. 51-102

  2. Health and economic burden due to malaria in Peru over 30 years (1990–2019): Findings from the global burden of diseases study 2019

    The Lancet Regional Health - Americas, Vol. 15

  3. Human Omental Mesothelial Cells Impart an Immunomodulatory Landscape Impeding B-and T-Cell Activation

    International Journal of Molecular Sciences, Vol. 23, Núm. 11

  4. Mesenchymal Stromal Cells for COVID-19 Critical Care Patients: A Present Hope

    Handbook of Stem Cell Therapy: Volume 1 (Springer Nature), pp. 163-191

  5. NR5A2/LRH-1 regulates the PTGS2-PGE2-PTGER1 pathway contributing to pancreatic islet survival and function

    iScience, Vol. 25, Núm. 5

2021

  1. A new shortened protocol to obtain islet-like cells from hESC-derived ductal cells

    In Vitro Cellular and Developmental Biology - Animal, Vol. 57, Núm. 6, pp. 587-597

  2. Editorial: A Compendium of Recent Research on Stem Cell-Based Therapy for Covid-19

    Frontiers in Cell and Developmental Biology

  3. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

    Trials, Vol. 22, Núm. 1